Table 1.
Clinical characteristics in subjects with and without MetS
| Variable | Non-MetS (n = 108) |
MetS (n = 86) |
P value |
|---|---|---|---|
| Age, years | 54.1 ± 9.6 | 53.4 ± 9.5 | 0.618 |
| Current smoking, % | 9.3 | 10.5 | 0.779 |
| Body mass index, kg/m2 | 26.0 ± 2.5 | 27.5 ± 1.7 | <0.0001** |
| Systolic blood pressure, mmHg | 130 ± 17 | 146 ± 17 | <0.0001** |
| Diastolic blood pressure, mmHg | 79 ± 11 | 87 ± 10 | <0.0001** |
| Fasting plasma glucose, mmol/L | 5.85 ± 2.30 | 7.42 ± 3.10 | <0.0001** |
| LDL-cholesterol, mmol/L | 3.32 ± 0.80 | 3.38 ± 0.77 | 0.628 |
| Triglyceride, mmol/L | 1.15 (0.88-1.47) | 1.88 (1.36-2.47) | <0.0001** |
| HDL-cholesterol, mmol/L | 1.71 ± 0.33 | 1.48 ± 0.38 | <0.0001** |
| Adiponectin, μg/mL | 8.95 (5.53-12.2) | 7.80 (4.80-10.9) | 0.050* |
| AT-LDL, μg/mL | 3.27 ± 1.02 | 3.00 ± 0.98 | 0.071 |
MetS: metabolic syndrome, LDL: low-density lipoprotein, HDL: high-density lipoprotein, α1-AT-LDL: α1-antitrypsin-low-density lipoprotein. Data are expressed as the mean ± standard deviation, the median (interquartile range) or the percentage in each subject group. Significance level (subjects without MetS vs. those with MetS; unpaired t-test [triglyceride and adiponectin were log-transformed] or χ2 test): * P ≤ 0.05, ** P ≤ 0.01.